Showing results (1-10 of 15) with videos related to
Sort By:
Pageof 2
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 1, 1990
Calcium channel blockers versus angiotensin-converting enzyme inhibitors: renal effectsS LinasThe American Journal of Physiology|July 1, 1996
Beta 2-adrenergic function in cultured rat proximal tubule epithelial cellsH Singh, S LinasThe American Journal of Physiology|January 1, 1997
Nitric oxide prevents neutrophil-mediated acute renal failureS Linas, D Whittenburg, J E RepineAIDS Education and Prevention : Official Publication of the International Society for AIDS Education|September 29, 2012
Sources of personal income and HIV risk among sexually active womenMelissa A Davey-Rothwell, Beth S Linas, Carl A LatkinKidney International|September 12, 1998
Alpha-melanocyte-stimulating hormone inhibits renal injury in the absence of neutrophilsH Chiao, Y Kohda, P McLeroy, et al.JMIR Mhealth and Uhealth|June 27, 2015
Uptake and Acceptability of Information and Communication Technology in a Community-Based Cohort of People Who Inject Drugs: Implications for Mobile Health InterventionsAndrew Genz, Gregory Kirk, Damani Piggott, et al.JMIR Mhealth and Uhealth|March 17, 2016
Ecological Momentary Assessment of Illicit Drug Use Compared to Biological and Self-Reported MethodsBeth S Linas, Andrew Genz, Ryan P Westergaard, et al.Drug and Alcohol Dependence|April 30, 2015
Utilizing mHealth methods to identify patterns of high risk illicit drug useBeth S Linas, Carl Latkin, Andrew Genz, et al.AIDS Research and Treatment|December 6, 2013
The exposure assessment in current time study: implementation, feasibility, and acceptability of real-time data collection in a community cohort of illicit drug usersGregory D Kirk, Beth S Linas, Ryan P Westergaard, et al.Addiction (Abingdon, England)|October 15, 2014
Capturing illicit drug use where and when it happens: an ecological momentary assessment of the social, physical and activity environment of using versus craving illicit drugsBeth S Linas, Carl Latkin, Ryan P Westergaard, et al.Pageof 2